Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm microtubule inner protein 5 (SPMIP5) is a protein localized to the cytoskeleton and specifically the axonemal A tubule inner sheath of the sperm flagellum, where it is part of the microtubule inner protein (MIP) complex associated with dynein-decorated doublet microtubules[1]. It is predicted to function by reinforcing and stabilizing the structure of microtubules in sperm flagella, thus playing a role in flagellated sperm motility[1]. No specific role in disease or drug targeting has been described, and its only established function is in male gamete physiology. The SPMIP5 gene is cataloged as a protein coding gene with identifiers including HGNC: 28500, NCBI Gene: 143379, and UniProtKB: Q8WW14[1][5]. SPMIP5 is predicted to be present in various cellular components involved in flagellar movement, including the cytoskeleton, motile cilium, axonemal A tubule inner sheath, and the sperm flagellum itself[1]. No current evidence supports a role for SPMIP5 as a therapeutic target, no clinical biomarkers, or relevant safety concerns are described in the scientific literature as of September 2025[1][5].
Not applicable (no therapeutic modulators known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm microtubule inner protein 5 (SPMIP5).